Work

Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson's Disease.

Year: 2017

Type: article

Abstract: for liposome in brain compared with 1,9-P suspension. Cytotoxicity assay showed no sign of toxicity, whereas apoptosis assay revealed a neuroprotective action of liposomes. The results demonstrated successful targeting of the 1,9-P, to brain as a novel strategy having significant therapeutic potential to treat PD.

Source: PubMed Central

Authors: Nilesh Sudhakar Ambhore, Kalidhindi Rama Satyanarayana Raju, Shashank Mulukutla, Karthik Yamjala, Shubhashri Mohire, Veera Venkata Satyanarayana Reddy Karri, Saurabh Gupta, Vishakantha Murthy, Kannan Elango

Institutions: JSS Academy of Higher Education and Research, JSS College of Pharmacy, Mayo Clinic

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: JSS College of Pharmacy, Indian Council of Medical Research

OpenAlex ID: W2762536915

FWCI: 0.268

Cites: 29

Cited by: 8

Related to: 10